What is DeepScribe?
DeepScribe operates at the intersection of artificial intelligence and clinical efficiency, providing a dual-purpose solution that integrates telemedicine platforms with automated medical documentation. By leveraging advanced machine learning, the company addresses the critical pain point of administrative burden for healthcare providers. Its technology enables seamless remote patient access while simultaneously generating accurate, real-time clinical notes. This dual-functionality not only enhances the quality of patient-provider interactions but also optimizes operational throughput, making DeepScribe a pivotal player in the modern HealthTech ecosystem. The company's market position is defined by its commitment to reducing physician burnout through intelligent, automated documentation, a necessity in the current high-demand healthcare environment.
How much funding has DeepScribe raised?
DeepScribe has raised a total of $35.2M across 2 funding rounds:
Angel/Seed
$5.2M
Unspecified
$30M
Angel/Seed (2021): $5.2M with participation from Wavemaker Three-Sixty Health, Skydeck, Stage 2 Capital, Supernode Ventures, Industry Ventures, 1984 Ventures, Foothill Ventures, Plug and Play Tech Center, and Sequoia Scout Fund
Unspecified (2022): $30M led by 1984 Ventures, Stage 2 Capital, Index Ventures, and Bee Partners
Key Investors in DeepScribe
Index Ventures
A global venture firm that partners with entrepreneurs from seed to IPO, known for backing transformative companies that challenge the status quo.
1984 Ventures
A San Francisco-based venture capital firm specializing in seed and early-stage investments, focusing on high-potential technology startups.
Wavemaker Three-Sixty Health
A specialized venture capital fund dedicated exclusively to early-stage healthcare startups, aiming to improve patient outcomes and lower costs through innovation.
What's next for DeepScribe?
With the recent influx of capital, DeepScribe is poised to transition from a high-growth startup to an enterprise-grade infrastructure provider. The strategic roadmap likely involves scaling its AI models to handle more complex medical specialties and expanding its integration capabilities with major Electronic Health Record (EHR) systems. As the company matures, the focus will shift toward achieving sustainable revenue growth and deepening its market penetration. By leveraging the expertise of its diverse investor base, DeepScribe is well-positioned to navigate the complexities of the healthcare regulatory landscape while continuing to innovate in the realm of automated clinical intelligence.
See full DeepScribe company page
